Oric Pharmaceuticals (ORIC) Operating Expenses (2019 - 2026)

Oric Pharmaceuticals' Operating Expenses history runs 8 years deep, the most recent figure standing at $39.6 million for Q1 2026.

• Quarterly Operating Expenses rose 21.09% year-over-year to $39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.9 million (up 2.24% YoY) and the FY2025 annual result came in at $143.0 million, changed 0.08% from the prior year.
• Operating Expenses was $39.6 million for Q1 2026 at Oric Pharmaceuticals, up from $34.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $39.6 million in Q1 2026 and bottomed at $20.7 million in Q2 2022.
• A 5-year average of $31.1 million and a median of $31.4 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses soared 44.11% — and 2025, when it dropped 12.68%.
• Oric Pharmaceuticals' Operating Expenses stood at $22.1 million in 2022, then soared by 42.09% to $31.4 million in 2023, then advanced by 25.91% to $39.6 million in 2024, then retreated by 12.68% to $34.6 million in 2025, then advanced by 14.67% to $39.6 million in 2026.
• Business Quant data shows ORIC's Operating Expenses at $39.6 million in Q1 2026, $34.6 million in Q4 2025, and $36.7 million in Q3 2025.